Replies to post #249836 on Biotech Values

[DewDiligence]

MRK.DE acquires SWTX for $47/sh cash—a 17% premium to SWTX’s “unaffected” share price on 2/7/25:

https://www.businesswire.com/news/home/20250427077657/en/Merck-KGaA-Darmstadt-Germany-to-Acquire-US-Biopharma-Company-SpringWorks-Therapeutics-to-Accelerate-Sustainable-Growth-of-Healthcare-Business

The enterprise value is $3.4B.